These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22890068)

  • 1. Incidence and clinical impact of fracture of drug-eluting stents widely used in current clinical practice: comparison with initial platform of sirolimus-eluting stent.
    Park MW; Chang K; Her SH; Lee JM; Choi YS; Kim DB; Kim PJ; Cho JS; Choi MS; Baek JY; Park CS; Yoon SG; Chung WS; Seung KB
    J Cardiol; 2012 Sep; 60(3):215-21. PubMed ID: 22890068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
    Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
    Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent.
    Li JJ; Xu B; Yang YJ; Chen JL; Qiao SB; Ma WH; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2007 Apr; 120(7):569-73. PubMed ID: 17442204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents.
    Byrne RA; Mehilli J; Iijima R; Schulz S; Pache J; Seyfarth M; Schömig A; Kastrati A
    Eur Heart J; 2009 Apr; 30(8):923-31. PubMed ID: 19240066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and clinical impact of stent fracture after everolimus-eluting stent implantation.
    Kuramitsu S; Iwabuchi M; Haraguchi T; Domei T; Nagae A; Hyodo M; Yamaji K; Soga Y; Arita T; Shirai S; Kondo K; Ando K; Sakai K; Goya M; Takabatake Y; Sonoda S; Yokoi H; Toyota F; Nosaka H; Nobuyoshi M
    Circ Cardiovasc Interv; 2012 Oct; 5(5):663-71. PubMed ID: 23011266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Procedural success and 10-month outcome between Cypher and TAXUS drug-eluting stents for the treatment of in-stent restenosis].
    Chen JL; Yang YJ; Qiao SB; Yao M; Qin XW; Xu B; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Li JJ; Gao RL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr; 35(4):305-7. PubMed ID: 17711652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency, predictors and outcome of stent fracture after sirolimus-eluting stent implantation.
    Umeda H; Gochi T; Iwase M; Izawa H; Shimizu T; Ishiki R; Inagaki H; Toyama J; Yokota M; Murohara T
    Int J Cardiol; 2009 Apr; 133(3):321-6. PubMed ID: 18342960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
    Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the incidence of late stent thrombosis after implantation of different drug-eluting stents in the real world coronary heart disease patients: three-year follow-up results.
    Chen JL; Gao LJ; Yang YJ; Li JJ; Qiao SB; Xu B; Huang JH; Yao M; Qin XW; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Gao RL
    Chin Med J (Engl); 2010 Apr; 123(7):778-81. PubMed ID: 20497663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
    Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of short- and mid-term outcomes between CYPHER and TAXUS stents in patients with complex lesions of the coronary arteries.
    Chen JL; Gao RL; Yang YJ; Qiao SB; Qin XW; Yao M; Liu HB; Xu B; Wu YJ; Yuan JQ; Chen J; Dai J; You SJ; Ma WH
    Chin Med J (Engl); 2006 Jan; 119(1):21-5. PubMed ID: 16454977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late catch-up phenomenon associated with stent fracture after sirolimus-eluting stent implantation: incidence and outcome.
    Serikawa T; Kawasaki T; Koga H; Orita Y; Ikeda S; Goto Y; Shintani Y; Kajiwara M; Tanaka H; Fukuyama T; Koga N
    J Interv Cardiol; 2011 Apr; 24(2):165-71. PubMed ID: 21198850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated drug-eluting stent implantation for drug-eluting stent restenosis: the same or a different stent.
    Cosgrave J; Melzi G; Corbett S; Biondi-Zoccai GG; Babic R; Airoldi F; Chieffo A; Sangiorgi GM; Montorfano M; Michev I; Carlino M; Colombo A
    Am Heart J; 2007 Mar; 153(3):354-9. PubMed ID: 17307411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.
    Takasawa Y; Iijima R; Shiba M; Nakamura M; Sugi K
    J Cardiol; 2010 May; 55(3):391-6. PubMed ID: 20350511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up results.
    Xu B; Dou KF; Han YL; Lü SZ; Yang YJ; Huo Y; Wang LF; Chen YD; Wang HC; Li WM; Chen JY; Wang L; Wang Y; Ge JB; Li W; Gao RL
    Chin Med J (Engl); 2011 Mar; 124(6):811-6. PubMed ID: 21518585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and predictors of drug-eluting stent fractures in long coronary disease.
    Kim HS; Kim YH; Lee SW; Park DW; Lee CW; Hong MK; Park SW; Ko JK; Park JH; Lee JH; Choi SW; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Park SJ;
    Int J Cardiol; 2009 Apr; 133(3):354-8. PubMed ID: 18508140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible predictors of target lesion revascularization after drug-eluting stent implantation.
    Yanagi D; Shirai K; Mori K; Ike A; Costantini CO; Costantini CR; Nishikawa H; Miller N; Zhang B; Tsuchiya Y; Urata H; Saku K
    J Cardiol; 2007 Feb; 49(2):63-7. PubMed ID: 17354579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion.
    Migliorini A; Moschi G; Vergara R; Parodi G; Carrabba N; Antoniucci D
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):344-8. PubMed ID: 16489559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.